Insider Transactions in Q1 2024 at Denali Therapeutics Inc. (DNLI)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 29
2024
|
Ryan J. Watts President and CEO |
SELL
Bona fide gift
|
Indirect |
40,000
-1.78%
|
-
|
|
Mar 15
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.37%
|
$33,320
$20.1 P/Share
|
|
Feb 15
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.35%
|
$29,988
$18.37 P/Share
|
|
Feb 14
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,405
-0.97%
|
$23,885
$17.79 P/Share
|
|
Feb 14
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
20,128
-9.7%
|
$342,176
$17.66 P/Share
|
|
Feb 13
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,784
-1.88%
|
$47,328
$17.29 P/Share
|
|
Feb 13
2024
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Direct |
9,589
-3.87%
|
$163,013
$17.29 P/Share
|
|
Feb 13
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
2,750
-1.93%
|
$46,750
$17.29 P/Share
|
|
Feb 13
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Direct |
2,716
-1.29%
|
$46,172
$17.29 P/Share
|
|
Feb 08
2024
|
Alexander O. Schuth COFO and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+19.22%
|
$0
$0.68 P/Share
|
|
Jan 16
2024
|
Vicki L Sato Director |
SELL
Open market or private sale
|
Direct |
1,666
-1.34%
|
$29,988
$18.42 P/Share
|
|
Jan 10
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,668
-3.06%
|
$88,692
$19.02 P/Share
|
|
Jan 09
2024
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
7,818
-0.34%
|
$148,542
$19.78 P/Share
|
|
Jan 05
2024
|
Steve E. Krognes Director |
SELL
Open market or private sale
|
Direct |
3,208
-2.2%
|
$60,952
$19.43 P/Share
|
|
Jan 05
2024
|
Carole Ho Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
9,972
-4.78%
|
$189,468
$19.43 P/Share
|
|
Jan 05
2024
|
Ryan J. Watts President and CEO |
SELL
Open market or private sale
|
Indirect |
17,483
-0.76%
|
$332,177
$19.43 P/Share
|
|
Jan 05
2024
|
Alexander O. Schuth COFO and Secretary |
SELL
Open market or private sale
|
Indirect |
9,972
-1.82%
|
$189,468
$19.43 P/Share
|
|
Jan 03
2024
|
Ryan J. Watts President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
89,520
+24.7%
|
-
|
|
Jan 03
2024
|
Carole Ho Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
53,720
+24.85%
|
-
|
|
Jan 03
2024
|
Alexander O. Schuth COFO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
53,720
+24.0%
|
-
|